(1R*,5S*)-8-(2-Fluoro-4-nitrophenyl)-8-azabicyclo[3.2.1]octan-3-one

被引：0
|
作者：
Yang, Tao [1 ]
Yang, Jianzhong [1 ]
Li, Zicheng [2 ]
Luo, Youfu [1 ]
机构：
[1] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Sch Chem Engn, Dept Pharmaceut & Bioengn, Chengdu 610065, Peoples R China
来源：
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2011年 / 67卷
关键词：
data-to-parameter ratio = 11.5; disorder in main residue; mean σ(C-C) = 0.003 Å; R factor = 0.044; single-crystal X-ray study; T = 293 K; wR factor = 0.113;
D O I：
10.1107/S1600536811047350
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
In the title compound, C13H13FN2O3, the fused piperidine ring is in a chair conformation. The fused pyrrolidine ring shows an envelope conformation with the N atom displaced by 0.661 (3) angstrom out of the plane formed by the four C atoms of the pyrrolidine ring. The dihedral angle between this plane and the plane formed by the four attached C atoms of the piperidine ring (not including the carbonyl C atom) is 67.63 (10)degrees. The F atom is disordered and was refined using a split model with an occupancy ratio of 0.910 (3): 0.080 (3).
引用
收藏
页码：O3297 / U1809
页数：8
相关论文
共 50 条
  • [31] Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1
    Brugel, Todd A.
    Smith, Reed W.
    Balestra, Michael
    Becker, Christopher
    Daniels, Thalia
    Hoerter, Tiffany N.
    Koether, Gerard M.
    Throner, Scott R.
    Panko, Laura M.
    Folmer, James J.
    Cacciola, Joseph
    Hunter, Angela M.
    Liu, Ruifeng
    Edwards, Philip D.
    Brown, Dean G.
    Gordon, John
    Ledonne, Norman C.
    Pietras, Mark
    Schroeder, Patricia
    Sygowski, Linda A.
    Hirata, Lee T.
    Zacco, Anna
    Peters, Matthew F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5847 - 5852
  • [32] Multistep Synthesis and Nematicidal Activity of 2-(8-azabicyclo[3.2.1]octan-3-yl)-3-imino-2,3-dihydro-1H-isoindol-1-One Derivatives
    Xu, Jun
    Yang, Tianjiao
    Wang, Jiayi
    Song, Gonghua
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2021, 57 (01) : 31 - 39
  • [33] The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists
    Napier, Susan
    Wishart, Grant
    Arbuckle, William
    Baker, James
    Barn, David
    Bingham, Matilda
    Brown, Angus
    Byford, Alan
    Claxton, Chris
    Craighead, Mark
    Buchanan, Kirsteen
    Fielding, Lee
    Gibson, Lindsay
    Goodwin, Richard
    Goutcher, Susan
    Irving, Nicholas
    MacSweeney, Cliona
    Milne, Rachel
    Mort, Chris
    Presland, Jeremy
    Sloan, Hazel
    Thomson, Fiona
    Turnbull, Zara
    Young, Trevor
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) : 3163 - 3167
  • [34] Preparation and crystal structure of (1S, 5S, 7S, 8R)-8-hydroxy-7-phenyl-2,6-dioxabicyclo [3.3.0]octan-3-one
    Langer, V
    Gyepesová, D
    Koman, M
    Kapitán, P
    Babjak, M
    Gracza, T
    Koós, M
    MOLECULES, 2003, 8 (07) : 599 - 606
  • [35] Multistep Synthesis and Nematicidal Activity of 2-(8-azabicyclo[3.2.1]octan-3-yl)-3-imino-2,3-dihydro-1H-isoindol-1-One Derivatives
    Jun Xu
    Tianjiao Yang
    Jiayi Wang
    Gonghua Song
    Chemistry of Heterocyclic Compounds, 2021, 57 : 31 - 39
  • [36] SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2
    Brugel, Todd A.
    Smith, Reed W.
    Balestra, Michael
    Becker, Christopher
    Daniels, Thalia
    Koether, Gerard M.
    Throner, Scott R.
    Panko, Laura M.
    Brown, Dean G.
    Liu, Ruifeng
    Gordon, John
    Peters, Matthew F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (18) : 5405 - 5410
  • [37] (Z)-2-(4-Methylbenzylidene)-1-azabicyclo[2.2.2]octan-3-one
    Sonar, Vijayakumar N.
    Venkataraj, M.
    Parkin, Sean
    Crooks, Peter A.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 : O5740 - O5741
  • [38] Relative configuration, absolute configuration and absolute structure of three isomeric 8-benzyl-2-[(4-bromophenyl)(hydroxy)methyl]-8-azabicyclo[3.2.1]octan-3-ones
    Brzezinski, Krzysztof
    Lazny, Ryszard
    Nodzewska, Aneta
    Sidorowicz, Katarzyna
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2013, 69 : 303 - U302
  • [39] Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models
    McLeod, Robbie L.
    Tulshian, Deen B.
    Bolser, Donald C.
    Varty, Geoffrey B.
    Baptista, Marco
    Fernandez, Xiomara
    Parra, Leonard E.
    Zimmer, Jennifer C.
    Erickson, Christine H.
    Ho, Ginny D.
    Jia, Yanlin
    Ng, Fay W.
    Korfmacher, Walter
    Xu, Xiaoying
    Veals, John
    Smith-Torhan, April
    Wainhaus, Samuel
    Fawzi, Ahmad B.
    Austin, Theodore M.
    van Heek, Margaret
    Hey, John A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 630 (1-3) : 112 - 120
  • [40] (1R,2R,3R,4S,5S)-3-Methyl-8-oxabicyclo[3.2.1]oct-6-ene-2,4-diyl diacetate
    Tafeenko, Viktor A.
    Aslanov, Leonid A.
    Proskurnina, Marina V.
    Sosonyuk, Sergei E.
    Khlevin, Dmitrii A.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2127 - U1347
12345